Corrigendum “Protective effects of E-CG-01 (3,4-Lacto cycloastragenol) against bleomycin-induced lung fibrosis in C57BL/6 mice” [Biomed. Pharmacother. 177 (2024) 117016] - 28/05/26

Kubilay Dogan Kilic ^{a, b, ⁎} , Derya Erisik ^a, Dilek Taskiran ^c, Kutsal Turhan ^{d, e}, Timur Kose ^f, Emel Oyku Cetin ^g, Aylin Sendemi̇r ^h, Yiğit Uyanikgil ^{a, i, j}

^a Ege University, Faculty of Medicine, Department of Histology and Embryology, İzmir, Turkiye 

^b Leibniz Institute for Evolution and Biodiversity Science, Museum für Naturkunde, Berlin, Germany 

^c Ege University, Faculty of Medicine, Department of Physiology, İzmir, Turkiye 

^d Ege University, Faculty of Medicine, Department of Thoracic Surgery, İzmir, Turkiye 

^e Acibadem Kent Hospital, Department of Thoracic Surgery, İzmir, Türkiye 

^f Ege University, Faculty of Medicine, Department of Biostatistics and Medical Informatics, İzmir, Turkiye 

^g Ege University, Faculty of Pharmacy, Department of Biopharmaceutics and Pharmacokinetics, İzmir, Turkiye 

^h Ege University, Faculty of Engineering, Department of Bioengineering, İzmir, Turkiye 

ⁱ Ege University, Cord Blood Cell – Tissue Research and Application Center, İzmir, Turkiye 

^j Ege University, Institute of Health Sciences, Department of Stem Cell, İzmir, Turkiye 

^⁎ Corresponding author at: Ege University, Faculty of Medicine, Department of Histology and Embryology, İzmir, Turkiye. Ege University, Faculty of Medicine, Department of Histology and Embryology İzmir Turkiye

Le texte complet de cet article est disponible en PDF.